Buy BPC-157 Peptide Today!
Direct Sarms New Zealand offers a wide variety of premium BPC-157 peptides for sale. Targeting the diverse needs of the research community with products tailored for various research applications.
BPC-157 is celebrated for its unparalleled healing and regenerative properties.
Product range includes BPC-157, available as a standalone peptide or in a blended formulation:
Peptide vials in multiple sizes (2mg, 5mg, 10mg). The vials are also available as complete kits featuring bacteriostatic water and syringes for convenience. There is the option to buy BPC-157 & Thymosin Beta 4 Capsules. Nasal sprays (available in 15ml and 30ml). Peptide stacks: This offer combines BPC-157 with another sought-after peptides in a cost-saving package, designed to provide our clients with exceptional value! Pre-mixed pens designed for ease of use.
Scientific References
(1) M.J.Hsieh et al (2016) – Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation – Journal of Molecular Medicine, 15 November 2016, Volume 95, pages 323–333.
(2) K.Skrlec et al (2018) Engineering recombinant Lactococcus lactis as a delivery vehicle for BPC-157 peptide with antioxidant activities – Applied Microbiology and Biotechnology, Volume 102, pages 10103–10117, (06 September 2018).
(3) C.H.Chang et al (1985) The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration – Journal of Applied Physiology, 2011 Mar;110(3):774-80.
(4) S.Seiwerth et al (2018) BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing – Current Pharmaceutical Design, 2018;24(18):1972-1989.
(5) D.Gwyer, N.M.Wragg, S.L.Wilson (2019) Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing – Cell and Tissue Research, 2019 Aug;377(2):153-159.
(6) P.Sikiric et al (2018) Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157. Vascular Recruitment and Gastrointestinal Tract Healing – Current Pharmaceutical Design, 2018;24(18):1990-2001.
(7) N.Jelovac et al (1999) Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats – European Journal of Pharmacology, 1999 Aug 20;379(1):19-31.
(8) A.Duzel (2018) Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights – World Journal of Gastroenterology, 2017 Dec 28;23(48):8465-8488.
ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY. DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our New Zealand Direct Sarms website is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.